About Us

Kristen Cahill, the President of Astralis BioPharma Consulting, brings nearly two decades of diverse experience in the Biotech and Pharmaceutical industry. Her career journey has been marked by a blend of consulting and permanent roles, providing her with a intricate understanding of the industry's nuances and challenges.

Driven by the commitment to continuous growth and the quest for an expansive, well-rounded knowledge base, Kristen strategically pursued cross-functional experience in crucial areas such as Clinical Operations, Clinical Quality Assurance, Clinical Outsourcing, Trial Master File (TMF) Operations, Good Clinical Practice (GCP) Auditing, Institutional Review Board (IRB), and Inspection Readiness enabling her to offer comprehensive solutions that address the multifaceted needs of clients.

The importance of continuous professional development has led her to earn a Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University. This advanced education further enhances her ability to navigate regulatory complexities and provide strategic guidance to clients in the ever-evolving Biotech and Pharmaceutical landscape. 

Kristen's leadership style is characterized by integrity, transparency, quality, and a commitment to excellence. She values sharing her unique expertise through mentorship; actively nurturing talent and guiding BioPharma professionals to reach their full potential.